Llanos-Cuentas, Alejandro
Schwalb, Alvaro
Quintana, Juan Luis
Delfin, Brian
Alvarez, Fiorela
Ugarte-Gil, César
Guerra Gronerth, Rosio I.
Lucchetti, Aldo
Grogl, Max
Gotuzzo, Eduardo
Article History
Received: 1 July 2022
Accepted: 30 January 2023
First Online: 28 February 2023
Declarations
:
: The study was approved by the independent ethics committee (IEC) Transitory National Committee of Ethics in Research (CNTEI, acronym in Spanish) from Peru, as process number CNTEI-003-200. This trial was conducted in compliance with the International Conference on Harmonisation (ICH-GCP) E6 on Good Clinical Practice and the clinical trial regulations for COVID-19 (Supreme Decree No. 014-2020 SA) from the National Health Institute (INS, acronym in Spanish). All participants gave written informed consent.
: Not applicable.
: The authors have no relevant financial or non-financial interests to disclose.